Intrauterine growth retardation (IUGR): epidemiology and etiology
- PMID: 19404231
Intrauterine growth retardation (IUGR): epidemiology and etiology
Abstract
Intrauterine growth retardation (IUGR) is mainly due to a pathologic slow-down in the fetal growth pace, resulting in a fetus that is unable to reach its growth potential. IUGR frequency will vary depending on the discrimination criteria adopted. It is extremely important to use local or national fetal growth graphs in order to avoid some confounding factors. IUGR incidence in newborns would be between 3% and 7% of the total population. In our experience it is 5.13% a figure similar to the one obtained by other authors but with a progressively higher incidence during the last decade. There are multiple maternal factors that can generally be grouped into constitutional and general factors given that they affect age, weight, race, maternal cardiac volume, etc, socioeconomic factors with key incidence in the mother's nutrition level, where a poor maternal nutrition level would be the key factor in this group. We have evaluated multiple factors as possible contributors to the IUGR risk: race, parents' age, mother's height (cm), mother's birth weight and before pregnancy (kg), ponderal gain and blood pressure during pregnancy, and previous SGA newborns. Socioeconomic factors like social class, parents' profession, habitual residence, salary, immigration, and diet were also evaluated. We also included variables such as total daily working time and time mothers spent standing up, daily sleeping time (hrs), stress self-perception test at work and primiparity age. Toxic factors during pregnancy: tobacco (active and passive), alcohol, drugs and coffee consumption. Fetal or utero-placental factors were considered. In our study, the most significant etiologic factors were: Active and passive tobacco consuming, mother's stress level, increase of total months worked during pregnancy, total daily working hours and time mothers spent standing up and finally, the parent's height. Our data support the main objective of reducing the incidence of SGA newborns after IUGR by fighting against tobacco from all fields, including the passive smoking habit, and improving the laboral conditions of the pregnant mother, lowering the number of daily hours worked, the physical activity and trying to avoid and to cope with stressful situations.
Similar articles
-
[Clinical condition of the newborn versus tobacco smoke exposure during fetal life].Przegl Lek. 2009;66(10):548-53. Przegl Lek. 2009. PMID: 20301877 Polish.
-
Maternal risk factors for low birth weight and intrauterine growth retardation in a Guatemalan population.Bull Pan Am Health Organ. 1991;25(2):152-65. Bull Pan Am Health Organ. 1991. PMID: 1893240
-
Coffee consumption and intrauterine growth retardation in Brazil.Eur J Clin Nutr. 1996 Nov;50(11):705-9. Eur J Clin Nutr. 1996. PMID: 8933114
-
Neurologic sequelae in infants with intrauterine growth retardation.J Reprod Med. 1978 Dec;21(6):343-51. J Reprod Med. 1978. PMID: 370385 Review.
-
[Pathogenesis of fetal growth retardation and behavioral disorders in the progeny caused by smoking during pregnancy].Vestn Akad Med Nauk SSSR. 1989;(3):42-50. Vestn Akad Med Nauk SSSR. 1989. PMID: 2658400 Review. Russian.
Cited by
-
The vascular effects of sodium tanshinone IIA sulphonate in rodent and human pregnancy.PLoS One. 2015 Mar 26;10(3):e0121897. doi: 10.1371/journal.pone.0121897. eCollection 2015. PLoS One. 2015. PMID: 25811628 Free PMC article.
-
Role of Adipose Tissue microRNAs in the Onset of Metabolic Diseases and Implications in the Context of the DOHaD.Cells. 2022 Nov 22;11(23):3711. doi: 10.3390/cells11233711. Cells. 2022. PMID: 36496971 Free PMC article. Review.
-
Ovine surgical model of uterine space restriction: interactive effects of uterine anomalies and multifetal gestations on fetal and placental growth.Biol Reprod. 2010 Nov;83(5):799-806. doi: 10.1095/biolreprod.110.085381. Epub 2010 Jun 23. Biol Reprod. 2010. PMID: 20574052 Free PMC article.
-
The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease.Cells. 2022 Feb 6;11(3):568. doi: 10.3390/cells11030568. Cells. 2022. PMID: 35159377 Free PMC article. Review.
-
Platelet Indices and CXCL12 Levels in Patients with Intrauterine Growth Restriction.Int J Womens Health. 2020 Apr 21;12:307-312. doi: 10.2147/IJWH.S233860. eCollection 2020. Int J Womens Health. 2020. PMID: 32368159 Free PMC article.